An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston |
Tag: Amgen Inc
Amgen aims to enter weight loss drug market with a new approach
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen
Tesla is one of the most oversold stocks, could be due for a rebound
It may be time to buy shares of Tesla as a popular metric on Wall Street indicates shares could be ripe for
Big pharma Merck, Bristol Myers, J&J prepare to lose revenue
The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium. NYSE Big pharmaceutical companies such as Bristol Myers
What Jim Cramer is watching to see where the stock market goes next
We don’t know what we want. This week, we will find out what it is that will propel us forward or turn
Boehringer Ingelheim, Terns, Viking may join market
Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a
Jim Cramer’s 4 stock ideas from JPMorgan Healthcare Conference
Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech
Apple longtime directors Al Gore and James Bell retiring from board
Former Vice President Al Gore speaks during the Agriculture Innovation Mission (AIM) for Climate Summit at the JW Marriott on May 08,
Market likes AI technology for advertising, not health care
CNBC’s Jim Cramer on Tuesday shared what he learned from his two days at JPMorgan‘s health-care conference. He marveled at the myriad
Fed-induced rally is unsustainable, especially for 5 sectors
It’s not being talked about enough. This market move off the November lows and the Fed pivot — signaling an end to
No More Posts Available.
No more pages to load.